Technology News and Research

RSS

Waters receives CE mark for MassTrak Immunosuppressants XE Kit

Waters Corporation (NYSE: WAT) today announced that its MassTrak™ Immunosuppressants XE Kit is now CE-marked in accordance with the IVD Directive 98/79/EC, for the quantitative measurement of the immunosuppressive drugs tacrolimus in liver and kidney transplant patients and everolimus in adult kidney and cardiac transplant patients from human whole blood samples as an aid in the management of immunosuppressant drug therapy.

25 Jul 2011

HCA second quarter revenues increase 4% to $8.063 billion

HCA Holdings, Inc. today announced financial and operating results for the second quarter ended June 30, 2011.

25 Jul 2011

Swaziland government, Vantage plan to construct pharmaceutical manufacturing facility

Vantage Health, announced today that it has been invited by the Ministry of Health for the Kingdom of Swaziland to plan the construction of a pharmaceutical manufacturing facility in that country.

25 Jul 2011

Roper Industries second quarter sales increase 23% to $700 million

Roper Industries, Inc. reported record financial results for the second quarter ended June 30, 2011.

25 Jul 2011

MiMedx second quarter revenue increases 85% to $1,929,000

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the second quarter and six months ended June 30, 2011.

25 Jul 2011

Valeritas' V-Go Disposable Insulin Delivery Device receives CE Mark approval

Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it received CE Mark approval for its V-Go Disposable Insulin Delivery Device as well as ISO 13485: 2003 Quality Management System Certification.

25 Jul 2011

Mayo Clinic trial to evaluate folate receptor alpha-targeted breast/ovarian cancer vaccine

VaxOnco, a leading oncology biopharmaceutical company, today announced that following FDA IND approval, it will sponsor a Phase I folate receptor alpha-targeted therapeutic vaccine clinical trial in disease-free patients, previously diagnosed with either breast or ovarian cancer at Mayo Clinic.

25 Jul 2011

Elsevier announces availability of iSpeech Audio Reader application

Elsevier, a world leading provider of scientific, technical and medical information products and services, today announced the availability of an audio reader application from iSpeech, provider of cloud-based speech technology and mobile apps, on SciVerse Applications beta.

25 Jul 2011

Study examines link between stereo 3D devices and visual discomfort

Several reports indicate that prolonged viewing of mobile devices and other stereo 3D devices leads to visual discomfort, fatigue and even headaches. According to a new Journal of Vision study, the root cause may be the demand on our eyes to focus on the screen and simultaneously adjust to the distance of the content.

25 Jul 2011

Glucose meters with functional DNA can detect a broad range of targets in a solution

Glucose meters aren't just for diabetics anymore. Thanks to University of Illinois chemists, they can be used as simple, portable, inexpensive meters for a number of target molecules in blood, serum, water or food.

25 Jul 2011

LAUNCH program focuses on sustainable energy challenges

The U.S. Agency for International Development (USAID), NASA, the U.S. Department of State, and NIKE, Inc. have partnered on a unique initiative called LAUNCH. The LAUNCH: Energy Challenge, announced today, formally begins the third module of the LAUNCH program which is focused on sustainable energy challenges for the developed and developing worlds.

25 Jul 2011

New method for detecting breast cancer at 'stage 0'

RNL Natural Co., Ltd, a leading biotech company specialized in adult stem cell therapeutics affiliated with RNL BIO Co., Ltd., introduced on June 22, 2011 a new method of detecting breast cancer as early as at 'stage 0' through breath VOCs.

25 Jul 2011

Sigma Life Science releases breast cancer-specific knockout and knockin cell lines for drug research

Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich, today announced the expansion of its CompoZr® Oncology Disease Model portfolio with the release of the first in its collection of breast cancer-specific knockout and knockin cell lines for drug discovery and research.

22 Jul 2011

New York eHealth Collaborative selects e-MDs as Meaningful Use Partner

e-MDs, a leading provider of electronic health records (EHRs), announced they have been selected as a Meaningful Use Partner by the New York eHealth Collaborative (NYeC). NYeC serves as the federally designated Health Information Technology Regional Extension Center (HITREC) for the state of New York, and works to promote and assist with the adoption of health IT technologies (HIT) across the state as well as develop HIT policies and standards.

22 Jul 2011

SG Austria acquisition benefits Nuvilex with $1.5M in grant funding

Nuvilex, Inc. announced today that as part of its acquisition of SG Austria, Nuvilex will benefit from grant funding previously awarded to SG Austria for its live-cell encapsulation activities and other projects. The total grant funding awarded to SG Austria is approximately $1.5 million.

22 Jul 2011

Prolonged viewing of mobile devices leads to visual discomfort, fatigue and headaches

22 Jul 2011

Elite task force provides insights and guidance on deep brain stimulation for dystonia

Neurologist Michele Tagliati, MD, director of the Movement Disorders Program at Cedars-Sinai Medical Center, served on an elite international task force commissioned by the Movement Disorder Society to provide insights and guidance on deep brain stimulation for dystonia, an uncommon condition that causes sustained, sometimes crippling muscle contractions.

22 Jul 2011

Advancements in use of zinc finger nucleases to produce genetically modified pigs

Sangamo BioSciences, Inc. announced the publication of a study demonstrating the use of zinc finger nucleases (ZFNs) to produce genetically modified pigs. The study, which was published in the Proceedings of the National Academy of Sciences (PNAS), represents a significant advancement in the development of improved, less immunogenic animal tissue as a source for transplant into humans.

22 Jul 2011

OCD introduces VITROS 4600 Chemistry System for high-volume laboratories

Ortho Clinical Diagnostics (OCD) today announced the launch of the VITROS® 4600 Chemistry System, a state-of-the-art analyzer that delivers high-quality, reliable test results for mid- to high-volume laboratories using the same core technologies that drive reliability and efficiency throughout OCD's portfolio of products.

From Ortho-Clinical Diagnostics, Inc. 22 Jul 2011

Combination of strategies reduces more than half the number of tiger mosquitos

The combination of three complementary measures to eradicate tiger mosquitos - avoid having stagnant water, using insecticides to eliminate larvae and adults, and removing rubbish - reduces more than half the number of tiger mosquitos, according to a research coordinated by researchers at Universitat Autonoma de Barcelona.

22 Jul 2011

Technology News and Research

Waters receives CE mark for MassTrak Immunosuppressants XE Kit

HCA second quarter revenues increase 4% to $8.063 billion

Swaziland government, Vantage plan to construct pharmaceutical manufacturing facility

Roper Industries second quarter sales increase 23% to $700 million

MiMedx second quarter revenue increases 85% to $1,929,000

Valeritas' V-Go Disposable Insulin Delivery Device receives CE Mark approval

Mayo Clinic trial to evaluate folate receptor alpha-targeted breast/ovarian cancer vaccine

Elsevier announces availability of iSpeech Audio Reader application

Study examines link between stereo 3D devices and visual discomfort

Glucose meters with functional DNA can detect a broad range of targets in a solution

LAUNCH program focuses on sustainable energy challenges

New method for detecting breast cancer at 'stage 0'

Sigma Life Science releases breast cancer-specific knockout and knockin cell lines for drug research

New York eHealth Collaborative selects e-MDs as Meaningful Use Partner

SG Austria acquisition benefits Nuvilex with $1.5M in grant funding

Prolonged viewing of mobile devices leads to visual discomfort, fatigue and headaches

Elite task force provides insights and guidance on deep brain stimulation for dystonia

Advancements in use of zinc finger nucleases to produce genetically modified pigs

OCD introduces VITROS 4600 Chemistry System for high-volume laboratories

Combination of strategies reduces more than half the number of tiger mosquitos

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News